Position in HCM
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$10,921
+$9,202 QoQ
Shares Held
1,015
+686.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 56 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $111,986 across 20 Drug Manufacturers - Specialty & Generic names. HCM ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
41 | $22,215 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,005 | $14,562 | |
| 3 | HCM |
HUTCHMED (China) Ltd
This page
|
1,015 | $10,921 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
488 | $7,822 | |
| 5 | VTRS |
Viatris Inc
|
454 | $7,209 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
41 | $6,910 | |
| 7 | ZTS |
Zoetis Inc.
|
94 | $6,754 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
264 | $6,497 |
All Filings in HCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,921 | 1,015 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $1,719 | 129 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,031 | 129 | Shares | Sole | 2025-11-21 | |
| 2025-03-31 | $556 | 37 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $533 | 37 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $722 | 37 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $633 | 37 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $621 | 37 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||